Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

T2 Biosystems CS (TTOO)

T2 Biosystems CS (TTOO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 276,678
  • Shares Outstanding, K 147,956
  • Annual Sales, $ 8,340 K
  • Annual Income, $ -59,010 K
  • 60-Month Beta 0.72
  • Price/Sales 13.42
  • Price/Cash Flow N/A
  • Price/Book 15.83
Trade TTOO with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate -0.06
  • Number of Estimates 1
  • High Estimate -0.06
  • Low Estimate -0.06
  • Prior Year -0.30
  • Growth Rate Est. (year over year) +80.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.0700 +74.77%
on 12/29/20
2.2200 -15.77%
on 01/12/21
+0.7400 (+65.49%)
since 12/22/20
3-Month
1.0100 +85.15%
on 11/25/20
2.2200 -15.77%
on 01/12/21
+0.5300 (+39.55%)
since 10/22/20
52-Week
0.2350 +695.74%
on 03/17/20
2.3100 -19.05%
on 07/01/20
+0.7000 (+59.83%)
since 01/22/20

Most Recent Stories

More News
Thinking about buying stock in T2 Biosystems, Zomedica, Aldeyra Therapeutics, La Jolla Pharmaceutical, or US Well Services?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for TTOO, ZOM, ALDX, LJPC, and USWS.

ZOM : 0.9562 (-4.38%)
TTOO : 1.8700 (-0.53%)
USWS : 0.8460 (+16.05%)
ALDX : 12.29 (+4.24%)
LJPC : 5.51 (+0.36%)
T2 Biosystems (TTOO) Jumps: Stock Rises 8.7%

T2 Biosystems (TTOO) saw a big move last session, as its shares jumped nearly 9% on the day, amid huge volumes.

HOLX : 75.70 (-0.29%)
TTOO : 1.8700 (-0.53%)
Thinking about buying stock in Hepion Pharmaceuticals, BioNano Genomics, T2 Biosystems, Surface Oncology, or Sesen Bio?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for HEPA, BNGO, TTOO, SURF, and SESN.

BNGO : 9.80 (+18.50%)
HEPA : 2.30 (-0.43%)
SESN : 1.6500 (-0.60%)
SURF : 13.31 (-0.75%)
TTOO : 1.8700 (-0.53%)
T2 Biosystems Set to Possibly Rebound After Yesterday's Selloff of 2.83%

T2 Biosystems (NASDAQ:TTOO) traded in a range yesterday that spanned from a low of $1.01 to a high of $1.05. Yesterday, the shares fell 2.8%, which took the trading range below the 3-day low of $1.05...

TTOO : 1.8700 (-0.53%)
T2 Biosystems to Participate in the Canaccord Genuity Virtual MedTech & Diagnostics Forum

T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced that the Company plans to participate in the upcoming Canaccord Genuity Virtual MedTech &...

MHMNF : 54.5000 (unch)
TTOO : 1.8700 (-0.53%)
T2 Biosystems (TTOO) Reports Q3 Loss, Tops Revenue Estimates

T2 Biosystems (TTOO) delivered earnings and revenue surprises of 20.00% and 32.45%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

TTOO : 1.8700 (-0.53%)
T2 Biosystems: 3Q Earnings Snapshot

LEXINGTON, Mass. (AP) _ T2 Biosystems Inc. (TTOO) on Wednesday reported a loss of $11.3 million in its third quarter.

TTOO : 1.8700 (-0.53%)
T2 Biosystems Announces Third Quarter 2020 Financial Results

T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced financial results for the third quarter ended September 30, 2020.

TTOO : 1.8700 (-0.53%)
Sepsis Alliance Elects T2 Biosystems CEO as Advisory Board Member

T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, and Sepsis Alliance, the first and leading sepsis nonprofit in the U.S., announced today that T2 Biosystems'...

TTOO : 1.8700 (-0.53%)
T2 Biosystems to Report Third Quarter 2020 Financial Results on November 4, 2020

T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, announced today that it will report financial results for the third quarter of 2020 after market close on...

TTOO : 1.8700 (-0.53%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

T2 Biosystems, Inc. is an in vitro diagnostics company. It has developed a technology platform that is designed to offer a rapid, sensitive and simple alternative to existing diagnostic methodologies. The Company uses its T2 Magnetic Resonance platform, or T2MR, that enables rapid detection of pathogens,...

See More

Key Turning Points

3rd Resistance Point 1.9650
2nd Resistance Point 1.9300
1st Resistance Point 1.9000
Last Price 1.8700
1st Support Level 1.8350
2nd Support Level 1.8000
3rd Support Level 1.7700

See More

52-Week High 2.3100
Last Price 1.8700
Fibonacci 61.8% 1.5173
Fibonacci 50% 1.2725
Fibonacci 38.2% 1.0276
52-Week Low 0.2350

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar